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Abstract In metabolomics, time-resolved, dynamic or
temporal data is more and more collected. The number of
methods to analyze such data, however, is very limited and
in most cases the dynamic nature of the data is not even
taken into account. This paper reviews current methods in
use for analyzing dynamic metabolomic data. Moreover,
some methods from other fields of science that may be of
use to analyze such dynamic metabolomics data are
described in some detail. The methods are put in a general
framework after providing a formal definition on what
constitutes a ‘dynamic’ method. Some of the methods are
illustrated with real-life metabolomics examples.
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Multivariate modeling  Dimension reduction 
Time series analysis  Basis functions
1 Introduction
In the last decade exciting science and innovation in Life
Sciences are driven from a systems view. Systems biology
has found a scientific focus due to advances in the high
throughput enabling technologies, measuring quickly at
different biological levels such as transcripts, proteins and
metabolites (Hood 2003; van der Greef et al. 2007; Wol-
kenhauer 2002). The progress of the systems based
approach is in a large part depending on developments in
biostatistics and bioinformatics to integrate high-dimen-
sional data to obtain a systems view. Many challenges
remain in this area some of which will be discussed.
A systems view recognizes that at different levels of a
complex system new properties are emerging and as a
consequence we need to study a system as a whole and not
by focusing on elements only. In addition to this, the multi-
level, interconnected, non-linear and dynamic properties
become the focus from which the self-organization of a
system can be understood. The dynamic characteristics
both from a measurement and biostatistics point of view
are becoming mandatory to reveal new system information,
e.g., to understand homeostasis and resilience after per-
turbation. Understanding health and disease based on
concepts as resilience can be understood from a biological
view, but the ability to measure and to analyze the complex
longitudinal high-dimensional data is mandatory to make
progress in research.
The concept of dynamic diseases was coined by Glass
and Mackey (1988) and the importance of biorhythms in
relation to health and disease as well as intervention are
surfacing as topics in multi-factorial disease etiology. From
a measurement point of view, metabolomics is an attractive
tool as it reveals information close to the phenotypic level
and it allows for large scale measurements in a robust way.
To set the stage, we first describe which type of dynamic
metabolomic data will be the topic of this paper. We will
not discuss approaches in metabolic flux analysis, since
that topic is covered elsewhere (Kholodenko 2004;
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Stephanopoulos et al. 1998) and occurs at a different time
scale involving other mechanisms than the data we want to
discuss. Also metabolic network inference methods through
dynamic data will not be discussed because this is a topic in
itself (Samoilov et al. (2001); van Berlo et al. (2003)). The
dynamic data we are going to discuss can originate from
different sources, depending on the relevant biological
question and the study design. In human metabolomics,
dynamic data from a challenge test may be available: a
person receives a challenge (e.g., a test meal) and blood is
sampled afterwards (Bijlsma et al. 2006) (time scale of
minutes/hours). This points to the topic of personalized food
and medicine where each person is subjected to a challenge
test that serves as a blueprint of the ‘metabolic status’ of that
person (van der Greef et al. 2006). In animal studies, also
serial tissue sampling (besides bodily fluids) might be
available (Kleemann et al. 2007) (time scale of hours/days).
Another example in animal studies is toxicology, where a
toxic compound is administered at different dosage levels
and samples of urine, blood and liver are collected in time
(Heijne et al. 2005; Keun et al. 2004) (time scale of hours/
days). A completely different type of dynamics is in
microbial metabolomics, where time-resolved measure-
ments are done on the intracellular metabolome of an
organism in a fermentation process (Rubingh et al. 2009)
(time scale of hours).
In this paper, we will focus on metabolomics data
(mostly) obtained through instruments such as NMR,
LC-MS and GC-MS. We will discuss methods to under-
stand underlying dynamic behavior of biological systems
based on analyzing metabolomics data. We will give an
overview on approaches taken in other fields such as
chemical engineering, systems theory and psychometrics.
Since these fields are very large, only those approaches are
discussed which are of potential use in metabolomics. The
existing approaches in transcriptomics will also be dis-
cusssed in this framework. We will discuss the methods in
the context of multivariate and high-dimensional data.
Multivariate means that for a single sample, multiple
metabolites are measured and in high-dimensional data,
many more metabolites are measured than samples. For
metabolomics, hardly any methods incorporating dynamics
exist sofar, to our best knowledge. We will specify this
statement later.
Three real-life data sets will be used as examples
throughout this paper to illustrate the working of some of
the methods. A brief introduction to the specifics of the
examples; building blocks of dynamic metabolomic data
analysis and a definition of ‘dynamics methods’ are also
provided to set the stage. Many of the methods reviewed
and proposed are not yet used in metabolomics, hence, the
area of dynamic metabolomics data analysis is still very
open for research.
2 Short description of the examples
Hormones are signaling and regulatory molecules. In
humans many hormones exhibit a circadian rhythm. There
are indications that the dynamic behavior of hormones are
related to disease states and also change upon treatment
(Kok et al. 2004, 2006). Hormones are secreted in pulses,
delivered to the bloodstream and subsequently degraded. In
the example, women were hospitalized for a study and
during a 24 h period, blood samples were taken every 10
min (n = 145 per individual). These blood samples were
analyzed for certain hormones, among them cortisol and
luteinizing hormone (LH). These measured hormone levels
are shown in Fig. 1 for one female. The data show clearly
pulsatile patterns.
The second example concerns NMR spectra of urine of
rhesus monkeys (Macaca mulatta) measured in time.
Samples are taken of ten monkeys (five male and five
female) at n = 29 days unevenly spread over a time course
of 57 days. This is a normality study: the monkeys were
kept in a non-stressed environment to study their natural
biorhythms. Details of the study were published elsewhere
(Jansen et al. 2004).
The third example is on nutrikinetics: the kinetic fate of
nutritional compounds (van Velzen et al. 2009). In a ran-
domized, placebo controlled double blind cross-over study,
20 healthy volunteers were subjected to a tea treatment.
NMR measurements were performed of their urine which
was collected over time (n varies between 9 and 14). This
allowed for estimating kinetic parameters for metabolites
in their urine.
3 Short description of methods
The potential viable methods are categorized in six groups
of methods where each group shares a similar underlying
idea. There is a loose ordering of the categories by the
amount of a priori knowledge needed to perform the data
analysis or, stated differently, by the strictness of the
imposed assumptions.
The first group consists of methods that are based on
fundamental models. This means that a priori knowledge
should be available about the functional form of the
dynamics for the metabolites. The second group consists of
methods based on predefined basis functions; such as
wavelets. Hence, some form of the dynamics must be
reasonable given the underlying biology. The third group
discusses dimension reduction methods, such as principal
component analysis. These methods work if there is an
underlying low dimensionality in the metabolomics data.
Group four discusses multivariate time series models,
which can be used if certain stationarity assumptions hold.
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Group five deals with analysis-of-variance (ANOVA) type
models and finally, the sixth group discusses methods
imposing smoothness, using the intrinsic consecutiveness
of time-resolved measurements.
When selecting a specific method for modeling dynamic
metabolomics data, it is useful to think in terms of the ‘data
generating process’. A possible data generating mechanism
is when the biological system under study is perturbed
thereby inducing changes in unobservable biological pro-
cesses. These in turn then affect the manifest variables,
which are the measured metabolites. Variations on this
theme are possible; this particular example is the idea
behind data generating processes for which dimension
reduction methods are suitable. Postulating a specific data
generating process presupposes knowledge about the bio-
logical system under study and the way the experimental
design has perturbed that system. Ideally, the knowledge
about the form of the dynamic system behavior as made
explicit in the data generation process is matched to the
requirements for the data analysis method. We will there-
fore make assumptions of the methods as explicit as
possible.
4 Building blocks
4.1 Fundamental models
Fundamental models of biological processes are usually
put in the framework of differential or difference equations.
These will therefore be discusses in some detail. Good
introductory textbooks exists for both linear (Fortmann and
Hitz 1977) and nonlinear dynamics (Strogatz 1994). The
general form of a first-order differential equation for x(t) is
_x ¼ f ðxðtÞ; t; aÞ; ð1Þ
where f(x(t), t;a) is a (possible nonlinear) function of
x(t) and t and only the first order derivative of x(t) is
present; the function f contains (possibly unknown)
parameters a. An example of a simple DE is
_x ¼ ax; ð2Þ
which is a first order (only first order derivatives), linear
(only linear terms in x), autonomous (time appears only
implicitly through x(t)) and homogenous (no forcing
functions or inputs) differential equation and the solution
of this equation is x = aeat for the initial condition
x(0) = a. Depending on the value of a, Eq. 1 has a stable
solution (a decreasing e-power for a\ 0) or an unstable
solution (an increasing e-power for a[ 0); for a ¼ 0; _x ¼
0; and x(t) = x(0) for all t. If x(0) = 0, the derivative _x ¼ 0
and the solution is then x(t) = 0 for all t and this solution is
indicated with x* (a fixed-point of Eq. 1). These solutions
show the typical behavior of linear first order differentail
equations: constant, blow-up or decaying towards zero.
Hence, no oscillations can take place.
A second order linear differential equation may look like
€x ¼ a1x þ a2 _x; ð3Þ
which can be rewritten as
_x ¼ y
_y ¼ a1x þ a2y;
ð4Þ
or, using obvious matrix notation
B
AFig. 1 Measured cortisol (a)
and luteinizing hormone (b)
levels in a woman during 1 day
showing pulsatility and
biorhythms
Dynamic metabolomic data analysis: a tutorial review 5
123
_x
_y
 
¼ 0 1
a1 a2
 
x
y
 
¼ A x
y
 
: ð5Þ
Hence, higher-order linear differential equations can
always be transformed to first-order systems. The solutions
of a second-order differential equation are richer in
behavior, e.g, oscillations are possible (Strogatz 1994).
These solutions are characterized by the eigenvectors and
eigenvalues of the system matrix A: there are oscillations if
the imaginary parts of the eigenvalues differ from zero.
Another way of expressing dynamics is in the form of
difference equations using discrete time points. Such an
equation can look like
xtþ1 ¼ gðxt; t; aÞ; ð6Þ
or, in a simple example
xtþ1 ¼ axt: ð7Þ
There are relationships between Eqs. 1 and 6 (Fortmann
and Hitz 1977) but that is beyond the scope of this paper. In
the sequel, continuous time functions are denoted as x(t)
and discrete time functions as xt.
Examples of using fundamental models and differential
equations will be given in Sect. 7.1 using both the hor-
mones and nutrikinetics data.
4.2 Time series models
A time series of a single metabolite can be approximated
with time series models such as an autoregressive process
of order 1 (AR(1))
xtþ1 ¼ hxt þ tþ1; ð8Þ
where h is the parameter to estimate and et is a so called
random shock. The parameter h has to obey a regularity
condition (|h| \ 1 for the AR(1) process) to be meaningful.
Alternatively, moving average (MA) processes can be used
xtþ1 ¼ tþ1  /t; ð9Þ
or combinations of both (ARMA processes),
xtþ1 ¼ hxt þ tþ1  /t; ð10Þ
which is an ARMA (1,1) model. These are also available
for higher orders and in nonlinear ways. It is important to
realize that Eqs. 8 and 9 make assumptions about the time
series xt. They both assume stationarity: the mean and
standard deviation do not depend on t and the autocovari-
ance only depends on s (the lag time is defined as a time
interval s = t2 - t1, where t1 and t2 are two time points of
the process). The autocovariance of an AR(1) model
decays exponentially as a function of the lag time and
for an MA(1) model the autocovariance is zero for lag
s[ 1. Hence, such models are not suitable for modeling
periodicity and oscillations since these would require
autocovariances with periodic lags. Although autocovari-
ances or autocorrelations strictly speaking can only be used
for stationary time series, they can also convey information
from general time series. Figure 2 shows the autocorrela-
tion function of the LH-hormone data of Fig. 1. This
autocorrelation function shows clearly periodicity which
relates to the periodicity in the original signals.
Second-order time series models look like
xtþ1 ¼ h1xt þ h2xt1 þ tþ1; ð11Þ
and such models are capable of describing damped
oscillations. They are more versatile in describing
dynamics with periodic events. A more versatile class of
times series models are ARIMA models, where the capital
‘I’ stands for integrating. Such models are also able to
describe non-stationary behavior. There is a host of
literature on how to estimate parameters in AR, MA and
ARIMA models, see e.g., Box et al. (1994).
4.3 Correlations
A key feature of multivariate measurements is the covari-
ation of the individual variables, usually measured in terms
of covariance or correlation. Covariance is a measure of
association of two random variables and appears as a set of
parameters in the multivariate distribution function of the
two random variables. For a bivariate normal distribution,
this comes down to
xNðl; RÞ ð12Þ
with
x ¼ x1
x2
 
; l ¼ l1
l2
 
; R ¼ r11 r12
r21 r22
 
; ð13Þ
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Fig. 2 An example of an autocorrelation function of the LH data
showing periodicity
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where rij is the covariance (or variance if i = j) of
variables xi and xj. In the context of dynamic
metabolomic data, consider the time sequences xt and
yt. If both metabolites are driven by, or probing, the same
underlying biological process, then they will show similar
behavior. Although this similarity can be described by a
covariance measure between xt and yt, this is, strictly
speaking, not a covariance (see, e.g., Anderson 2003).
The correct way of describing their mutual behavior is by
writing
xt ¼ cxnt þ mx;t
yt ¼ cynt þ my;t;
ð14Þ
where nt represents the underlying dynamic process, cx, cy
are parameters and mx,t, my,t are disturbances. Depending on
the variances of these disturbances relative to the variation
in nt and the sizes of cx, cy, the time series xt and yt show
similar behavior. From now on, we will use the concepts of
covariance and correlation for the association between xt
and yt, although this is a simplification.
4.4 Dimension reduction
When measuring many metabolites, a way to bringing
down the complexity of the data is using (linear) dimension
reduction of which there are essentially two classes of
methods: (common) factor analysis and principal compo-
nent analysis. The factor analysis model for the vector x
(J 9 1) containing the measured metabolites can be written
as
x ¼ Ky þ  þ l; ð15Þ
where KðJ  RÞ is a matrix of constants (loadings); y (R
9 1) and e(J 9 1) are random vectors. The elements of y
are called common factors and the elements of e specific or
unique factors. The vector l is a vector of means of x. This
model is a direct extension of model (14). Upon making
assumptions regarding distributions and independence of
terms, the parameters of model (15) can be estimated
(Mardia et al. 1979). In words, the factor analysis model
tries to model the covariance structure of the variables in x
by using common factors.
Principal component analysis (PCA) can be interpreted
in different ways: a transformation of the original variables
or as a subspace approximation method (see, Smilde et al.
(2004) for an extensive discussion). The transformation
comes down to z0 = x0P where z is an (R 9 1) vector of
scores and P a (J 9 R) matrix of loadings. This equation is
invertible for J = R resulting in x0 = z0P0 or x = Pz, and
upon deciding on the value of R (usually smaller than J,)
x = Pz becomes an approximation of x. This is usually
expressed in the equation
X ¼ ZP0 þ E; ð16Þ
where X is the T 9 J matrix containing the measured time
series; Z (T 9 R) contains the time series component
scores; P (J 9 R) is the loading matrix and E (T 9 J) the
matrix of residuals. The loading matrix P maximizes the
variance of the scores and minimizes the sum of squared
residuals. Hence, PCA focusses on the variance of x.
Both PCA and factor analysis models reduce the
dimensionality of the original problem (J) to R, where R
is usually much smaller than J. There are differences
between the models (Mardia et al. 1979; Jolliffe 1986),
e.g, PCA does not provide facilities for the unique factors
and the factors y are no linear combinations of the
x-variables (note that the z variables are indeed linear
combinations of the variables in X). If the unique factor
contributions are small relative to the common factor
contributions, PCA and factor analysis give similar
results.
The factors y and scores z are sometimes called latent
variables to distinguish them from the the manifest vari-
ables x. Although this nomenclature is somewhat sloppy in
the case of PCA, the term nicely illustrates the basic
assumption underlying the PCA and factor analysis mod-
els: the variation in x is summarized by a small set of
underlying and unobservable variables.
4.5 What are dynamic methods?
It is useful to give a precise definition of a dynamic met-
abolomics data analysis method. This will be done with the
example of PCA which is not a dynamic method in our
definition.
Suppose a metabolomics data set is available where ten
metabolite concentrations are measured at five time points.
The resulting matrix has five rows and ten columns rep-
resenting the measured metabolite values and can be
decomposed using PCA. For simplicity, only the first
principal component is considered. The PCA results in
score vector zorig and loading vector porig. Next, the ori-
ginal data are shuffled, such that the time evolution
between the rows is broken. The subsequent PCA of the
data the gives scores zshuffled and loadings pshuffled. After
this PCA, the zshuffled can be reshuffled thereby undoing the
initial shuffling. The resulting scores zreshuffled are exactly
equal to the original scores zorig, and it also holds that
porig = pshuffled = preshuffled. Hence, PCA is insensitive to
the evolutionary nature of the time axis and is thus not a
dynamic metabolomics method. The definition of a
dynamic metabolomic data analysis method is now simple:
that method should be sensitive to the evolutionary nature
of the time axis.
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5 Dynamic metabolomic data analysis
5.1 Fundamental models
When a time series for a single metabolite is measured
(denoted as xt) and the form of the difference equation is
known, then finding dynamics comes down to estimating
unknown parameters a in the difference equation
xtþ1 ¼ f ðxt; aÞ; ð17Þ
where an autonomous system is assumed (no explicit t in
(17)). Several methods exists for estimating the parameters
a. One of those methods is using least squares (or nonlinear
least squares), however, such problems can be very com-
plicated in terms of irregular error surfaces and very cor-
related parameter estimates. Moreover, they have the risk
of getting stuck in local minima. This can be avoided to
some extent by using natural computational methods such
as genetic algorithms or simulated annealing (Apostu and
Mackey 2008). A viable alternative is to use smoothness
constraints for regularization, thereby making the error
surface less rugged and the problem better solvable
(Ramsay et al. 2007).
An example of using a difference equation in practice
are hormone dynamics. A simple model describing mea-
sured dynamic hormone behavior in human blood is
xt ¼ xt1ek þ /t þ t; ð18Þ
where t is the index for time points, the parameter k is the
first-order decay constant, /t is the pulsatility function and
et is the measurement error. The pulsatility function /t is
nonlinear and represents the secreted hormone. This
function can be defined in different ways (Vis et al. 2009).
Hence, Eq. 18 is an example of a nonlinear non-autono-
mous difference equation.
The measured hormone levels are shown in Fig. 3 as dots
in the upper panel. The pulsatility function was constrained
to have only a limited number of pulses (bars in middle
panel). The decay is clearly visible in the slopes of the
drawn line (upper panel) and the residual e is presented in
the lower panel. The model fits the data well, and gives a
decay rate and information about pulsatile behavior
important for endocrinologists to study normal physiology
and pathophysiology (including diseases).
The idea of using difference equations can be general-
ized to multiple metabolite measurements. When mea-
surements are available on J metabolites as a function of
time, then these can be symbolized as xt (J 9 1). A second-
order nonlinear difference equation for such a vector is then
xtþ1 ¼ Fðxt; xt1; aÞ; ð19Þ
where an autonomous system is assumed, F : R2J ! RJ
is a vector valued function and a is a set of parameters.
The underlying biology or physiology dictates the specific
form of the function F and it comes down to estimating
parameters a. In principle, the same methods can be used as
in the univariate case, but the multivariate problem is
usually much harder to solve. An example for a system of
two genes can be found in the gene-expression literature
(Cao and Zhao 2008).
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Pulse identification in 24−hr LH time series.Fig. 3 Measured and fitted
luteinizing hormone (LH)
during 1 day. Legend: dots
upper panel are original data;
drawn line upper panel is fitted
model; bars middle panel are
estimated hormone pulses; line
lower panel are residuals
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For a large number of metabolites and for high dimen-
sional a fitting a set of difference equations is difficult.
Moreover, in most cases the exact form of F is unknown
and alternative models have to be discriminated with a
limited set of samples. This poses a challenging experi-
mental design question: at which time points should the
samples been taken to optimally discriminate between
competing models?
An alternative to modeling simultaneously all measured
metabolites in one single set of equations is to first select the
most important metabolites and model only those. This
route was taken in the nutrikinetics example, where data
analysis preselected three metabolites of potential interest.
Subsequently, for each metabolite and each subject a set of
two coupled fundamental models were used: one describing
the behavior under placebo conditions and one the behavior
under treatment conditions. The power of this approach is
that each subject serves as her/his placebo thereby reducing
the inter-person variability dramatically. This is especially
important in nutritional studies because the effect sizes are
usually small (van Velzen et al. 2008). The equations to
describe the behavior of the cumulative excreted metabolite
in the placebo (xpla) and treatment (xtea) period are
xplanp ¼ apla þ btnp þ planp ð20Þ
xteant ¼ atea þ btnt þ xteamaxð1  ekeðtntsÞÞ þ teant ; tnt  s
ð21Þ
xteant ¼ atea þ btnt þ teant ; tnt\s
where ‘pla’ abbreviates placebo; ‘tea’ abbreviates the
treatment with tea; tnp, tnt indicate the time points of
measurements for placebo and treatment periods, respec-
tively (these are not equal). The parameters to estimate are
s (lag time); apla, atea (off sets); b (linear cumulative
increase); xteamax (maximum output of metabolite); and ke
(first-order rate constant). The sums of squared values of
eplanp and e
tea
nt are simultaneously minimized using a least
squares fit. The working of these equations is shown in
Fig. 4. After fitting the data, the estimated parameters can
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Fig. 4 Nutrikinetic modeling.
The dots and stars represent
measured metabolite
concentrations at different time
points. Shown are the original
data (a); the net treatment effect
(b) and the model residuals (c).
Some of the parameters,
explained in the text, are also
indicated
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be used for phenotyping. For instance, the net cumulative
urinary excretion after 48 h can be calculated as
bxteanet ¼ bxteamaxð1  ebkeð48bsÞÞ
and, subsequently, can be used to characterize individual
metabolic status (van Velzen et al. 2009).
5.2 Basis functions
If the underlying biology dictates a certain preset form or
basis function of the dynamics, then this form can be
fitted to the data. Some basis functions (e.g., monotonic
decreasing, monotonic increasing and unimodal profiles)
are shown in Fig. 5. Examples of the use of splines as
basis functions for dynamic data can be found in the
gene-expression literature (de Hoon et al. 2002; Storey
et al. 2005). No examples are available for similar
approaches in metabolomics. One of the reasons may be
that postulating basis functions for dynamic metabolomic
data is not that easy. Once the basis functions are chosen,
the approach is simple because it comes down to simple
regression steps. Usually, only few parameters are
required and hence the sample sizes can be small. After
fitting the individual metabolomic time profiles on the
basis functions, the best fitting ones are selected and
metabolites with a similar time course behavior are
clustered. Hence, a special type of correlation is found,
namely the covariation with basis functions. These basis
functions are guesses of underlying functions nt and,
hence, fit in the framework of (15). This procedure will
automatically give a dimension reduction because the
basis functions serve as ‘latent’ variables.
For periodic or oscillating time series, Fourier Analysis
or Wavelet transformations can be used. Fourier Analysis
requires large sample sizes and repeated patterns; in that
respect Wavelets are more flexible. For the analysis of
high-dimensional metabolomics data, forcing the latent
time variables to follow a wavelet or Fourier transform
structure is worthwhile. Combining wavelets with principal
component analysis is already done in chemical engineer-
ing (Bakshi 1998). A sophisticated way of using basis
functions is by means of hidden Markov models (Schliep
et al. 2003). The basis functions are implicitly defined in
the emission densities of the hidden nodes, thereby also
allowing for some flexibility and adaptation of the
functions.
5.3 Dimension reducing methods
Usually in metabolomics, many variables are measured,
this can range from 100 to 1000 (Bijlsma et al. 2006).
Clearly, finding underlying dynamics in such data has to
be simplified by reducing the number of variables. This
can be done in several ways: by selecting important
variables or by dimension reducing methods. The latter
class of methods is very broad and versatile: principal
component analysis, factor analysis, including all their
lagged and dynamic versions. Those will be discussed in
some detail.
Variable selection can be done in various ways. If
biological knowledge is available, then this should drive
the selection. However, in most metabolomics applica-
tions discovery of new biology is the goal and hence prior
information for selecting the most important variables is
by definition not available. Then data driven variable
selection techniques have to be used which is a risky
undertaking. Although there exist many methods for
variable selection in ‘classical’ statistics (e.g. for regres-
sion problems forward selection, backward elimination
and stepwise regression), the main problem in high-
dimensional data sets is overfitting. By testing (almost) all
combinations of variables in a high-dimensional problem,
this number becomes so high that overfitting cannot be
avoided. Hence, such a selection has always to be
accompanied with a good validation strategy to avoid the
so-called selection bias (Ambroise and McLachlan 2002).
The whole topic of variable selection, including proper
validation, deserves a critical review in itself. Obviously,
upon assuming that we have selected a number of rele-
vant variables, preferably using a priori biological
knowledge, we can use some of the dynamic methods as
exemplified in this paper.Fig. 5 Examples of simple basis functions
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Combining a priori knowledge of the underlying
dynamics with a dimension reduction approach is best
explained by using the factor analysis framework:
xt ¼ Kyt þ t þ l
ytþ1 ¼ f ðyt; t; aÞ;
ð22Þ
where, again, a contains the (unknown) parameters. The
issue is the form of the functional relationship f. Either this
function is known or it has to be estimated from the data.
To the best of our knowledge, models like (22) have not
been explored in X-omics data analysis. Model (22) can be
simplified (dropping the term l for simplicity) by
postulating
xt ¼ Kyt þ t
ytþ1 ¼ Hyt;
ð23Þ
where the dynamics are in the latent variables yt in a simple
way. This is a combination of dimension reduction and
time series analysis.
The idea of making factor analysis models dynamic can
also be implemented differently (dropping again the
term l). Dynamic factor analysis (Molenaar 1985) models
the data as
xt ¼
XL
l¼0
Klytl þ t; ð24Þ
where yt contains the R factor scores at time t and these
factors scores are assumed to be generated by a white noise
process (uncorrelated). The index l stands for lag and, hence,
lags upto and including L are considered. All the dynamics in
xt is captured by the lagged loading matrices Kl .
Component models can also be made dynamic. Besides
the obvious extension of (16) where the scores zt are forced
to follow a predefined dynamic model, there are two
alternative ways of constructing dynamic PCA models,
called lagged-PCA and dynamic PCA. Lagged-PCA is a
simplified version of the more general Lagged Simulta-
neous Component Analysis (Timmerman 2001) for ana-
lyzing multiple data sets simultaneously. To explain the
idea of lagged-PCA, it is convenient to introduce the
backshift matrix Bl - where l = 0,…, L defines the time
lags - which is defined as follows
Bl ¼ ½0TðLlÞjIT j0Tl: ð25Þ
Using the scores Z ((T ? L) 9 R), the loadings P (J 9 R),
and residuals E (T 9 J), the lagged-PCA model becomes
X ¼
XL
l¼0
BlZP
0
l þ E: ð26Þ
A small numerical example for L = 2 is given to illustrate
the working of this model:
B0Z ¼
0 0 1 0 0 0 0
0 0 0 1 0 0 0
0 0 0 0 1 0 0
0 0 0 0 0 1 0
0 0 0 0 0 0 1
0
BBBB@
1
CCCCA
1 2
3 4
5 6
7 8
9 10
11 12
13 14
0
BBBBBBBB@
1
CCCCCCCCA
¼
5 6
7 8
9 10
11 12
13 14
0
BBBB@
1
CCCCA; ð27Þ
which shows the implicitly defined zero shift matrix B0 and
scores Z. The first lag is modelled as
B1Z ¼
0 1 0 0 0 0 0
0 0 1 0 0 0 0
0 0 0 1 0 0 0
0 0 0 0 1 0 0
0 0 0 0 0 1 0
0
BBBB@
1
CCCCA
1 2
3 4
5 6
7 8
9 10
11 12
13 14
0
BBBBBBBB@
1
CCCCCCCCA
¼
3 4
5 6
7 8
9 10
11 12
0
BBBB@
1
CCCCA; ð28Þ
and the second lag is modelled as
B2Z ¼
1 0 0 0 0 0 0
0 1 0 0 0 0 0
0 0 1 0 0 0 0
0 0 0 1 0 0 0
0 0 0 0 1 0 0
0
BBBB@
1
CCCCA
1 2
3 4
5 6
7 8
9 10
11 12
13 14
0
BBBBBBBB@
1
CCCCCCCCA
¼
1 2
3 4
5 6
7 8
9 10
0
BBBB@
1
CCCCA; ð29Þ
which results in the model of X:
X ¼ B0ZP00 þ B1ZP01 þ B2ZP03 þ E: ð30Þ
Clearly, the lagged-PCA model has three sets of loadings
(P0, P1 and P2) representing the relationships between
the variables in X and the scores Z at different lag-
times.
The backshift operator works on the scores in lagged-
PCA, this operator can also work directly on the X matrix,
resulting in dynamic-PCA (Ku et al. 1995). The idea is
shown using a simple example for X:
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X ¼
1 8
2 9
3 10
4 11
5 12
6 13
7 14
0
BBBBBBBB@
1
CCCCCCCCA
ð31Þ
in which the rows represent time points and columns
metabolites. Upon using backshift operators, the submatrices
B0X ¼
3 10
4 11
5 12
6 13
7 14
0
BBBB@
1
CCCCA; B1X ¼
2 9
3 10
4 11
5 12
6 13
0
BBBB@
1
CCCCA; B2X
¼
1 8
2 9
3 10
4 11
5 12
0
BBBB@
1
CCCCA; ð32Þ
can be concatenated to form eX
eX ¼ B0XjB1XjB2X½  ð33Þ
which can then be subjected to an ordinary PCA. Hence,
the dynamics are in the manifest variables and subse-
quently, a PCA captures these dynamics. Note that the
covariance matrix of eX contains three types of covariances:
(i) those between variables (lag = 0), (ii) those within
different time points of the same variables (auto-covari-
ance) and (iii) those between different time points of dif-
ferent variables (cross-covariance). Hence, the subsequent
PCA-scores capture a mixture of these three, obscuring the
individual contributions.
In fact, matrix eX is a matricized three-way array (Kiers
(2000)) X of size T 9 J 9 L. Hence, an alternative would
be to analyze this array with PARAFAC or Tucker3
models (Smilde et al. 2004). It is difficult to say how many
samples are needed for stable results for the estimates of
the different dynamic factor analysis, lagged-PCA and
dynamic-PCA models. A disadvantage of dynamic-PCA is
that it ‘cuts off’ parts of X (the higher L the more severe
this cut-off is) thereby reducing the number of samples in
the time direction. This stability will depend on the mea-
surement error, the intrinsic dynamics and the complexity
(i.e., intrinsic rank) of X.
Dynamic-PCA also has a close cousin called dynamic-
PLS. There are three alternatives for dynamic-PLS. The
first version takes lagged x-variables and performs then an
ordinary PLS between the expanded (and lagged) X matrix
and the phenotype y. This procedure is based on Finite
Impuls Response models as used in systems identification
(Ljung 1987). An extension of this is to incorporate also
lagged y-variables in the new X-block (Qin and McAvoy
1996).This is a direct generalization of the ARMA mod-
eling strategy (see below). The drawback of both methods
is that the X matrix (which is already huge) is even
expanded with many lagged variables thereby aggravating
the problem of low sample-to-variables ratio’s. Hence, this
does not seem to be a viable route to take, despite the
dimension reduction capability of PLS.
An alternative is presented in the process control liter-
ature and consists of defining a dynamic filter to account
for the dynamics in X and, subsequently, building an
(static) model between the filtered X and y with PLS
(Kaspar and Ray 1993). Stated otherwise, the dynamics in
X are ‘whitened’ and then related to y. Although this
approach does not have the drawback of ‘blowing-up’ the
dimensions of X unfavorably, it is sensitive to the specified
form the filter. Tuning such a filter might not be a trivial
task in dynamic metabolomics.
Another way to account for dynamics is to use time as
an external variable. This is the approach taken by batch
modelling (Wold et al. 1998). The idea is building a PLS
model between X (T 9 J) and a y-vector containing either a
maturity variable or the time corresponding to the sampling
of the rows of X (see Fig. 6).
A maturity variable is a measured variable indicating the
progress of the biological process. In both cases, the PLS
model finds features in X related to a time axis and as such
is a dynamic approach. This approach has been used in
several metabolomics applications (Antti et al. 2002;
Jonsson et al. 2006), but has also some drawbacks. One of
the problems of this approach is that it will poorly describe
features in X that do not align with the imposed time axis
(Westerhuis et al. 1999). A new method has been published
based on OPLS models to describe successive differences
between two adjacent time points (Rantalainen et al. 2008).
The drawback of this method is that the time trajectory
information is given in a set of models hampering
interpretation.
5.4 Time series analysis
There exists a multivariate extension of time series models:
xtþ1 ¼ Hxt þ t; ð34Þ
which is a multivariate AR(1) model (or a Vector AR(1)
model) with H an J 9 J matrix of coefficients and et a
J-valued vector of random shocks. Again, the matrix H has
to fulfill some regularity conditions. Extension to second-
order systems and moving average models also exist.
Estimating the model parameters H is possible, but
requires a lot of samples for stable results, especially if J is
rather large (Holtz-Eakin et al. 1988).
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For regression type problems, ARMAX models can be
used. An example of an ARMAX (1,1) model is
ytþ1 ¼ hyt þ u1xtþ1 þ u2xt þ tþ1; ð35Þ
where h, u1 and u2 are parameters to be estimated. The
time lags used for x and y are both 1, hence the notation
ARMAX (1,1) model.
An alternative is to write the set of difference equations
in state-space notation,
xtþ1 ¼ Axt þ But
yt ¼ Cxt þ t;
ð36Þ
where A is the J 9 J system matrix, C the K 9 J
measurement matrix, ut a M 9 1 vector of inputs and B an
M 9 J input transfer matrix and y (k 9 1) the vector of
measurements (Fortmann and Hitz 1977; Ljung 1987). For
generality, the forcing term B ut is introduced. In the case
of metabolomics experiments, this forcing term is usually
complicated. This forcing term can be a diet, a toxic
compound or an administered drug. Then B represents the
influence of such an intervention directly on the
metabolites, which is hard to estimate and is usually not
explicitly considered. Since we consider all measured
metabolites, C = I (the identity matrix). Then, by
rearranging (36) and solving for yt, we get
ytþ1 ¼ Ayt þ tþ1  At; ð37Þ
which is a multivariate ARMA (1,1) model, showing the
intimate relationship between time series models and state-
space models. Some application of state-space models are
reported in the gene-expression literature (Wu et al. 2004)
but to our knowlegde, no applications have been reported
in metabolomics.
State-space models can also be combined with dimen-
sion reduction when the state variables xt are regarded as
underlying (latent) variables and yt represent the measured
metabolites. The matrix C then relates the manifest to the
latent variables and the dimensionality of xt can be much
lower than yt. The dynamics are now imposed on the latent
variables. This approach differs from dynamic factor
analysis (see Eq. 3) because in the latter case the time
instances of the latent variables are considered as inde-
pendent gaussian.
5.5 ANOVA
A different way of tackling dynamic data is by using anal-
ysis of variance (ANOVA) models (Searle 1971). In such
models, the factor time can be accounted for in both a
qualitative and quantitative way. The qualitative analysis
pertains to modeling the factor ‘time’ at its different levels,
whereas the quantitative analysis models the factor ‘time’ in
terms (of mixtures) of linear, quadratic and/or cubic trends
(depending on the number of time points available). A
convenient way of quantitative modeling is by using
orthogonal polynomials, since the consecutive terms in such
polynomials are orthogonal thereby facilitating the estima-
tion process. In the gene-expression literature, there are
examples of both qualitative modeling (Storey et al. 2005),
as well as quantitative modeling (Conesa et al. 2006).
The multivariate extension of ANOVA is called Multi-
variate Analysis of Variance. This extension is not
straightforward (e.g., which test statistic to use (Stahle and
Wold 1990) and it is not clear how to use it for multivariate
time-resolved data (e.g., how to treat the factor time).
Moreover, high-dimensional data gives singular covariance
Fig. 6 Batch process modeling:
a PLS model is built between
time-resolved measured
metabolites (collected in X and
a y-variable measuring time.
The score vectors t1 and t2 are
obtained from the PLS
modeling
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matrices. One way to generalize ANOVA to the high-
dimensional case is by performing separate ANOVA’s on
the individual metabolite profiles thereby partitioning the
data according to sources of variation. Subsequent simul-
taneous component analysis (SCA) models on the different
parts of the data perform then the necessary dimension
reduction. These approaches, called multilevel-SCA
(MSCA) and ANOVA-SCA (ASCA), have been used
succesfully in psychometrics (Timmerman and Kiers
2003), metabolomics (Jansen et al. 2004, 2005; Smilde
et al. 2005; Vis et al. 2007), proteomics (Harrington et al.
2005), geneexpression (Nueda et al. 2007) and also in
process chemometrics (de Noord and Theobald 2005).
There exists also a multiway version: PARAFASCA
(Jansen et al. 2008). The ASCA methods do not assume
linear time behavior and is therefore a general method for
capturing nonlinear time behavior (Smilde et al. 2008).
An alternative - called SMART - is to apply special
preprocessing steps of the metabolomics data and perform
a subsequent PCA (Keun et al. 2004). SMART has some
drawbacks, notably its lack of orthogonal partitioning
hampering interpretation (Jansen et al. 2005). Moreover,
SMART is not a dynamic method according to our defi-
nition. ASCA is only a dynamic method if the factor time is
treated in a quantitative way in the ANOVA model.
A route taken in the gene-expression literature is to
perform single ANOVA’s per gene and then cluster the
results afterwards (Conesa et al. 2006). It is also possible to
combine both steps by using mixture modeling to find
genes with a similar time behavior and estimate the
dynamic behavior then for the whole cluster simulta-
neously (Rodriguez-Zas et al. 2006). This amounts to a
considerable reduction of parameters to estimate. This
procedure can also be used in metabolomics.
5.6 Smoothness
A very general approach to account for the consecutiveness
of time evolving processes is by using smoothness con-
straints. In terms of curve fitting of a single metabolite time
profile, this approach can be described as
min
y
jjx  yjj2 þ kjjDyjj2
h i
; ð38Þ
where x = (x1, ..., xT )
0 is the vector of original time series
measurements, y contains the fitted (or smoothed) values
y = (y1, ..., yT )
0, D is a matrix differentiating consecutive
elements of y and k C 0 is a metaparameter regulating the
constraint ||Dy||2 (Eilers 2003; Ramsay and Silverman
1997). There are also other constraints possible, e.g., pen-
alties on second-order differences in (38)
A way to combine ideas of consecutiveness with
dimension reduction in time-resolved high-dimensional
metabolomics data is to make the estimated principal
component scores ‘as autocorrelated as possible’. The
method Maximum Autocorrelation Factors (MAF) does
this for spatially resolved data, and can be used directly for
the time-resolved data (Larsen 2002). This method calcu-
lates components zr, r = 1,…, R for which the lag l entries
have a maximum autocorrelation, while being mutually
orthogonal across r = 1,…, R. The lag l has to be chosen
by the user. Interestingly, the MAF method is equivalent to
the Molgedy-Schuster version of Independent Component
Analysis (Larsen 2002). Hence, using Molgedy-Schuster
Independent Component Analysis on the time-resolved
data would also invoke consecutiveness.
Combining smoothness with dimension reduction can be
done by applying smooth-PCA (Westerhuis et al. 2008).
The smooth-PCA method models the data by solving
min
Z;P
jjX  ZP0jj2 þ kjjDZjj2
h i
; ð39Þ
where again D is a first-order or second-order difference
matrix and k 0 is a penalty parameter. The higher the
value of k, the smoother the scores in Z will become.
An example will be shown for the monkey data and, for
simplicity, results will only be shown for a typical female
monkey, although an analysis using all ten monkeys (i.e.,
smooth-Simultaneous Component Analysis) would also be
possible. Prior to analysis, the data were mean-centered
across the time-mode. A smooth-PCA is compared to a
normal (non-smooth) PCA. To calculate the smooth-PCA,
a second-order penalty was used in (39) and a special
arrangement has to be made to accommodate for the non-
equidistant sampling scheme (Westerhuis et al. 2008).
The first score vectors are shown for different values of
k, see Fig. 7.
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Fig. 7 Scores of the first PC and smooth-PC. Legend: the numbers 0
and 3 refer to the value of k
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For k = 0, the PCA solution is obtained. Raising k
penalizes roughness more and makes the scores smoother.
It is hard to give objective criteria to select k, but a value of
3 seems reasonable, whereas a value of 30 (result not
shown) gives a too smooth solution. The first score vector
shows a rhythm with a period of 27–28 days which may be
due to the oestric cycle (Xu et al. 2007). The corresponding
loadings are shown in Fig. 8, and do not differ much
between normal PCA and smooth-PCA. The first score
explains 21.9% of the variation in the data, whereas the
solution with k = 3 explains 13.8%. Hence, the loss of
variance explained should be compensated by a better
interpretability. A detailed interpretation of these results is
outside the scope of this paper.
6 Discussion
It would be nice to end this paper with giving a scheme on
when to apply which method in what situation. As in all
statistical modeling situations, the dynamic modeling pro-
cess is also an art without predefined rules.
First, the type of biological question, the amount of
knowledge of the system and the availability of data is
important. If a phenotypic variable is available, then this
variable might steer the unravelling of the dynamics in the
metabolome data. Looking for specific rhythms with
known dynamics calls for different methods than exploring
dynamic patterns in metabolomics data of relatively
unknown organisms.
Second, the experimental design is important, the
number of time points, their spacing in time and the
number of metabolites measured. The design puts restric-
tions on the methods to use. Some of the methods require
many time-resolved samples (time series methods) whereas
other methods can do with a limited number (basis func-
tions). With high-dimensional data, it is worthwhile to
consider methods involving dimension reduction.
Third, the type of measurements performed is important.
For example, NMR and MS data have different charac-
teristics and these should be kept in mind when using
dynamic methods. Some of the methods are easily adapted
to accommodate nonhomogeneous errors. Such an adaption
might be profitable in terms of the quality of the estimated
parameters.
Preferably, the choices for measurement and data anal-
ysis are driven by the biological question, the data gener-
ating process, the experimental design and the assumptions
of the data analysis methods.
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which per-
mits any noncommercial use, distribution, and reproduction in any
medium, provided the original author(s) and source are credited.
Notation
x (vector) bold lowercase
X (matrix) bold uppercase
t = 1,…, T time index (T = number of time points)
j = 1,…, J variable index (J = number of
variables)
l = 0,…, L lagging index (L = number of time
lags)
r = 1,…, R principal component index (R =
number of principal components)
Bl (T 9 (T ? L)) back-shift operator for lag l
U (I 9 I) left singular vectors of X
S (I 9 I) diagonal matrix containing (in descend-
ingorder) the singular values of X
V (J 9 I) right singular vectors of X
U1 (I 9 R) R ‘largest’ left singular vectors ofX
S1 (R 9 R) R largest singular values of X
V1 (J 9 R) R ‘largest’ right singular vectors ofX
Z (T 9 R) scores in a PCA model of X
P (J 9 R) loadings in a PCA model of X
A (J 9 J) system matrix
D (T 9 T) difference matrix
K(T 9 R loading matrix in factor analysis
h parameter(s) in AR models
/ parameter(s) in MA models
u parameter(s) in the X part of ARMAX
models
a parameter(s) in DE’s and DFE’s
et (scalar) random shock, random error or
specific factor
k (scalar) penalty parameter in penalized
methods
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Fig. 8 Loadings of the first PC and smooth-PC. Legend: drawn line
is PCA and dotted line is smooth-PCA
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